Emergent BioSolutions traded at $32.84 this Wednesday July 6th, decreasing $0.42 or 1.26 percent since the previous trading session. Looking back, over the last four weeks, Emergent BioSolutions lost 1.42 percent. Over the last 12 months, its price fell by 46.63 percent. Looking ahead, we forecast Emergent BioSolutions to be priced at 30.97 by the end of this quarter and at 28.52 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Acadia Pharmaceuticals 15.12 -0.15 -0.98% -36.92%
Akebia Therapeutics 0.46 0.05 12.47% -86.39%
ALKERMES 31.87 0.44 1.40% 25.03%
Alnylam Pharmaceuticals 150.00 -0.73 -0.48% -13.09%
Amarin 1.56 -0.03 -1.89% -63.29%
ANI Pharmaceuticals 31.82 -0.13 -0.41% -4.44%
BioMarin Pharmaceutical 86.41 0.05 0.06% 4.06%
Coherus Biosciences 8.88 0.34 3.98% -33.73%
Chimerix 2.29 -0.05 -2.14% -70.41%
Emergent BioSolutions 32.84 -0.42 -1.26% -46.63%
Exact Sciences 43.29 -1.11 -2.50% -63.23%
Exelixis 21.53 -0.74 -3.32% 19.81%
Glaxosmithkline 43.11 -0.19 -0.44% 7.13%
Heron Therapeutics 3.14 0.14 4.67% -77.76%
Intercept Pharmaceuticals 15.29 0.14 0.92% -19.44%
Immunogen 5.15 0.25 5.10% -16.94%
Ionis Pharmaceuticals 36.81 -1.04 -2.75% -5.52%
Ironwood Pharmaceuticals 11.87 0 0% -3.50%
Jazz Pharmaceuticals 160.44 0.40 0.25% -12.81%
Lonza Group 548.20 18.60 3.51% -19.29%
Lexicon Pharmaceuticals 2.63 -0.12 -4.36% -32.39%
Merck & Co 93.13 0.49 0.53% 18.55%
Moderna Inc 159.56 4.02 2.58% -28.09%
Myriad Genetics 19.01 0.17 0.90% -40.69%
Neurocrine Biosciences 95.20 -3.10 -3.15% -3.05%
Nektar Therapeutics 3.90 -0.03 -0.76% -76.53%
Opko Health 2.74 0.09 3.40% -28.83%
Pacira 57.66 -0.69 -1.18% 1.62%
Pfizer 52.75 1.11 2.15% 34.05%
PTC Therapeutics 42.91 -0.87 -1.99% -2.57%
Sanofi 97.90 0.78 0.80% 12.79%
Seattle Genetics 175.13 -1.64 -0.93% 16.96%
Sarepta Therapeutics 75.97 0.23 0.30% 5.53%
Teva Pharmaceutical Industries 7.55 -0.16 -2.08% -19.08%
United Therapeutics 241.90 4.75 2.00% 29.37%
Vanda Pharmaceuticals 11.69 0.19 1.65% -42.10%
Xoma 22.24 1.24 5.90% -33.27%

Indexes Price Day Year
US2000 1728 -13.78 -0.79% -23.32%
US400 2279 -13.85 -0.60% -15.05%

Emergent BioSolutions
Emergent BioSolutions Inc. is a life sciences company focused on providing civilian and military populations with a portfolio of preparedness and response products and solutions that address accidental, deliberate and naturally occurring public health threats (PHTs). The Company is focused on five PHT categories: Chemical, Biological, Radiological, Nuclear and Explosives (CBRNE); emerging infectious diseases (EID); travel health; emerging health crises; acute/emergency care; and contract development and manufacturing (CDMO). It operates through four business units, which includes three product business units: Vaccines, Devices, Therapeutics; and one services business unit: CDMO. The Company's contract development and manufacturing service offerings cover development services, drug substance manufacturing and drug product manufacturing across the pharmaceutical and biotechnology industries as well as the United States Government (USG) and non-Governmental organizations.